Article Sidebar
Main Article Content
Abstract
Le syndrome de Terson est l’association d’une hémorragie vitréenne, rétro hyaloïde, rétinienne ou sous-rétinienne avec une hémorragie sous arachnoïdienne. Il reste encore sous diagnostiqué dans notre milieu. Le cas que nous rapportons est celui d’une patiente de 29 ans qui a présenté une hémorragie vitréenne bilatérale consécutive à une hémorragie sous arachnoïdienne. L’angiographie par résonance magnétique cérébrale a montré un anévrysme sacciforme de la terminaison de l’artère carotide interne gauche. Un traitement endovasculaire (embolisation) a été indiqué pour l’anévrysme et une attitude conservatrice pour l’hémorragie vitréenne. L’évolution a été favorable.
ABSTRACT
Terson’s syndrome is the occurrence of vitreous, retrohyaloid, retinal or subretinal haemorrhage with a subarachnoid haemorrhage. This pathology is still underrecognized in our setting. We report here the case of a 29-year-old female with bilateral vitreous haemorrhage and subarachnoid haemorrhage. Cerebral magnetic resonance angiography showed a saccular aneurysm of the terminal internal left carotid artery. An aneurysm embolization was planned and an expectant management for the vitreous haemorrhage. The evolution was favorable.
Article Details
References
- Michalewska Z, Michalewski J, Nawrocki J. Possible methods of blood entrance in Terson syndrome. Ophthalmic Surg Lasers Imaging. Nov-Dec 2010;41 Suppl: S42-9.
- Ko F, Knox DL. The Ocular Pathology of Terson’s Syndrome. Ophthalmology. 2010 Jul; 117(7):1423-9.
- Skevas C, Czorlich P, Knospe V, Stemplewitz B, Richard G, Westphal M, Regelsberger J, Wagenfeld L. Terson’s Syndrome-Rate and Surgical Approach in Patients with Subarachnoid Hemorrhage: A Prospective Interdisciplinary Study. Ophthalmology. 2014 Mar 31.
- Ou R Jr., Talavera F, Charles S, Roy H, Phillpotts B, Yoshizumi M. Terson Syndrome treatment and management. Med Scape. 2014; 13:312–318.
- Stienen MN, Lücke S, Gautschi OP, Harders A. Terson haemorrhage in patients suffering aneurysmal subarachnoid haemorrhage: a prospective analysis of 60 consecutive patients. ClinNeurolNeurosurg. 2012 Jul;114(6):535-8.
- Middleton K, Esselman P, Lim PC. Terson syndrome: an underrecognized cause of reversible vision loss in patients with subarachnoid hemorrhage. Am J Phys Med Rehabil. 2012 Mar; 91(3):271-4.
- Glatt H, Machemer R. Experimental subretinal hemorrhage in rabbits. Am J Ophthalmol. 1982; 94:762-773.
- Toosi SH, Malton M. Terson’s syndrome – significance of ocular findings. Ann Ophthalmol. 1987; 19:7-12.
- Skevas C, Czorlich P, Knospe V, Stemplewitz B, Richard G, Westphal M, Regelsberger J, Wagenfeld L. Terson’s Syndrome-Rate and Surgical Approach in Patients with Subarachnoid Hemorrhage: A Prospective Interdisciplinary Study. Ophthalmology. 2014 Mar 31.
- Garweg JG, Koerner F. Outcome indicators for vitrectomy in Terson syndrome. Acta Ophthalmol. 2009;87(2):222-6.
- Czaplicka E, Grabska-Liberek I, Rospond I, Kocięcki J. Zespół Tersona — omówienie przypadków klinicznychi postępowania leczniczego. Borgis — Postępy
- Nauk Medycznych 2013; 12:901–903.
- Nacef L, Zghal-Mokni I, Allagui I. Indications and results of vitrectomy in Terson syndrome. Tunis Med. 2004; 82:461–464.
References
Michalewska Z, Michalewski J, Nawrocki J. Possible methods of blood entrance in Terson syndrome. Ophthalmic Surg Lasers Imaging. Nov-Dec 2010;41 Suppl: S42-9.
Ko F, Knox DL. The Ocular Pathology of Terson’s Syndrome. Ophthalmology. 2010 Jul; 117(7):1423-9.
Skevas C, Czorlich P, Knospe V, Stemplewitz B, Richard G, Westphal M, Regelsberger J, Wagenfeld L. Terson’s Syndrome-Rate and Surgical Approach in Patients with Subarachnoid Hemorrhage: A Prospective Interdisciplinary Study. Ophthalmology. 2014 Mar 31.
Ou R Jr., Talavera F, Charles S, Roy H, Phillpotts B, Yoshizumi M. Terson Syndrome treatment and management. Med Scape. 2014; 13:312–318.
Stienen MN, Lücke S, Gautschi OP, Harders A. Terson haemorrhage in patients suffering aneurysmal subarachnoid haemorrhage: a prospective analysis of 60 consecutive patients. ClinNeurolNeurosurg. 2012 Jul;114(6):535-8.
Middleton K, Esselman P, Lim PC. Terson syndrome: an underrecognized cause of reversible vision loss in patients with subarachnoid hemorrhage. Am J Phys Med Rehabil. 2012 Mar; 91(3):271-4.
Glatt H, Machemer R. Experimental subretinal hemorrhage in rabbits. Am J Ophthalmol. 1982; 94:762-773.
Toosi SH, Malton M. Terson’s syndrome – significance of ocular findings. Ann Ophthalmol. 1987; 19:7-12.
Skevas C, Czorlich P, Knospe V, Stemplewitz B, Richard G, Westphal M, Regelsberger J, Wagenfeld L. Terson’s Syndrome-Rate and Surgical Approach in Patients with Subarachnoid Hemorrhage: A Prospective Interdisciplinary Study. Ophthalmology. 2014 Mar 31.
Garweg JG, Koerner F. Outcome indicators for vitrectomy in Terson syndrome. Acta Ophthalmol. 2009;87(2):222-6.
Czaplicka E, Grabska-Liberek I, Rospond I, Kocięcki J. Zespół Tersona — omówienie przypadków klinicznychi postępowania leczniczego. Borgis — Postępy
Nauk Medycznych 2013; 12:901–903.
Nacef L, Zghal-Mokni I, Allagui I. Indications and results of vitrectomy in Terson syndrome. Tunis Med. 2004; 82:461–464.